Form 4: Editas Medicine Director Receives Stock Grant
Insider Transaction (Form 4)
Patrick Thomas Ellinor Ii, a Director of Editas Medicine, Inc., received 103,400 shares of common stock on August 6, 2026.
Summary
- Grant/award: acquired 103,400 Stock Option (right to buy) on August 6, 2026; holds 103,400 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Patrick Thomas Ellinor Ii — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-06 | Grant/award | Stock Option (right to buy) | 103,400 | — | — | 103,400 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-06 | Grant/award (103,400 shares) |
Keywords
insider transaction, Form 4, EDIT, Editas Medicine, Inc., neutral, Patrick Thomas Ellinor Ii
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.